$PG

Procter & Gamble beats estimates but guidance disappoints

Procter & Gamble (PG) reported Q1 earnings of $2.00 per share, beating estimates by $0.11, with revenue of $23.28 billion, up 4% YoY. However, its full-year guidance fell short of expectations, with core EPS guidance of $6.89-$7.11, below the $7.39 consensus. The company cited higher costs as a challenge. Shares rose 1.70% in pre-market trading.

Original reporting
Published Oct 22, 2026, 11:13 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 22, 2026, 11:18 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$PG
Bearish
high confidence
Mentioned
$PG
Relevance
8/10
AlphAI data visualization · based on investing.com
Decision brief

The 30-second read

$PGBearishHigh
01

Why it matters

The guidance miss is a fresh, material data point for a large‑cap consumer staple, likely prompting a price correction.

02

Market read

Earnings beat with guidance shortfall creates immediate trading relevance for PG and may affect the consumer‑staples sector.

03

What to watch

Higher commodity costs and net interest expense may be temporary, and the Thorne acquisition could drive future growth.

Relevance 8/10Novelty 8/10Timing: pre‑market today

Background

Procter & Gamble posted Q1 earnings that beat estimates, but its FY2027 EPS guidance fell short of Wall Street expectations, highlighting cost pressures.

Company-level read

Ticker impact

$PGBearishHigh confidence
Context

PG reported Q1 earnings beat but full-year EPS guidance of $6.89‑$7.11 missed consensus of $7.39, prompting a 1.7% pre‑market rise then likely downside pressure.

Expected impact

likely pressure as the market prices in the guidance miss

Evidence & confidence

The earnings beat is offset by guidance below consensus, a material new data point for a large‑cap consumer staple.

Market effects

Consumer staples may see broader valuation pressure if guidance misses become a trend.

U.S. markets likely dip in consumer‑staples indices.

Limited; impact confined to U.S. and global consumer‑goods investors.

Counterpoint

The beat on earnings and strong cash flow could support a short‑term rally despite guidance miss.

Key entities

  • Procter & Gamble Co.

    Consumer goods conglomerate reporting Q1 results and FY guidance.

Related articles

$PGHighAI 8/10

P&G’s Q1 Results Draw Price-Target Hikes As Analysts Cite Stronger Underlying Performance

Procter & Gamble (P&G) reported Q1 adjusted earnings of $2.00 per share, beating estimates, with revenue of $23.28 billion also topping forecasts. The company maintained its fiscal 2027 organic sales and EPS growth outlooks but raised its all-in sales growth outlook to 2%-4% due to its acquisition of Thorne. P&G also increased its estimated fiscal 2027 after-tax commodity cost headwind to $1.4 billion.

$PGHighAI 8/10

TD Cowen raises Procter & Gamble stock price target on turnaround progress

TD Cowen raised its price target for Procter & Gamble (NYSE:PG) to $166 from $150, citing strong Q1 performance and potential for full-year guidance. The firm maintained a Hold rating due to uncertainty about U.S. momentum. PG reported Q1 earnings of $2.00 per share on $23.28B revenue, exceeding estimates. Morgan Stanley also raised its target to $185, highlighting profit upside.

$PGHighAI 8/10

PG Q1 Earnings Call Highlights Growth Amid Rising Cost Pressures

Procter & Gamble (PG) reported Q1 fiscal 2027 earnings of $2.00 per share, beating estimates, with revenues up 4% to $23.28 billion. Management highlighted organic growth but cautioned about rising commodity costs. PG maintained its full-year outlook, expecting 1-3% organic sales growth and 0-3% core earnings growth. Higher costs are pressuring margins, with a projected $1.9 billion after-tax headwind.

$PGHighAI 8/10

Procter & Gamble Co (PG) (Q1 2027) Earnings Call Highlights: Broad-Based Organic Growth

Procter & Gamble (PG) reported Q1 2027 earnings with organic sales growth of 4% and volume growth of 2%. Margins declined due to higher costs, with a $1.4B after-tax impact expected for fiscal '27. Guidance suggests a deceleration in organic sales growth to 3% in the first half. CFO Andre Schulten attributed margin improvements to productivity gains and restructuring. Challenges include commodity cost headwinds, foreign exchange, and higher interest expenses.

$PGHighAI 9/10

Procter & Gamble Co (PG) (Q1 2027) Earnings Call Highlights: Bro

Procter & Gamble (PG) reported Q1 2027 earnings with organic sales up 4.0% and core EPS at $2.00. All 10 product categories and six regions grew. Margins declined due to higher costs. FY27 guidance: 1-3% sales growth, 0-3% core EPS growth, and $15 billion in cash returns. Commodity and FX headwinds are expected to impact earnings.